Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Beatriz Tejera SeguraIrene Altabás GonzálezIñigo Rúa-FigueroaNatalia Pérez VeigaVictor Del Campo PérezAlejandro Olivé-MarquésMaría GalindoJaime CalvoJuan Gabriel Ovalles-BonillaAntonio Fernandez-NebroRaúl Menor-AlmagroEva TomeroNatividad Del Val Del AmoEsther Uriarte IsacelayaFrancisco Javier NarváezJose L AndreuAlina BoteanuJavier NarváezAtusa MovasatCarlos MontillaJose Miguel Senabre GallegoBlanca Hernández-CruzMariano AndrésEva SalgadoMercedes FreireSergio Machín GarcíaClara MorianoLorena ExpósitoClara Pérez VelásquezM L Velloso-FeijooAna Paula CachedaNuria Lozano-RivasGema BonillaMarta ArévaloInmaculada JiménezVíctor Quevedo-VilaFrancisco J Manero-RuizPaloma García de la Peña LefebvreTomás Ramón Vázquez-RodríguezJesús Ibañez-RuaTatiana Cobo-IbañezJose María Pego-ReigosaPublished in: Rheumatology (Oxford, England) (2021)
Having GI damage is associated with a worse prognosis. Patients on a high dose of glucocorticoids are at higher risk of developing GI damage which reinforces the strategy of minimizing glucocorticoids. Oral ulcers appear to decrease the risk of GI damage.